title: Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.
abstract: Knowing the pathophysiology of trauma-induced coagulopathy is important for the management of severely injured trauma patients. The aims of this review are to provide a summary of the recent advances in our understanding of thrombosis and hemostasis following trauma and to discuss the pathogenesis of disseminated intravascular coagulation (DIC) at an early stage of trauma. Local hemostasis and thrombosis respectively act to induce physiological wound healing of injuries and innate immune responses to damaged-self following trauma. However, if overwhelmed by systemic inflammation caused by extensive tissue damage and tissue hypoperfusion, both of these processes foster systemic DIC associated with pathological fibrin(ogen)olysis. This is called DIC with the fibrinolytic phenotype, which is characterized by the activation of coagulation, consumption coagulopathy, insufficient control of coagulation, and increased fibrin(ogen)olysis. Irrespective of microvascular thrombosis, the condition shows systemic thrombin generation as well as its activation in the circulation and extensive damage to the microvasculature endothelium. DIC with the fibrinolytic phenotype gives rise to oozing-type non-surgical bleeding and greatly affects the prognosis of trauma patients. The coexistences of hypothermia, acidosis, and dilution aggravate DIC and lead to so-called trauma-induced coagulopathy. He that would know what shall be must consider what has been. The Analects of Confucius.
authors.affiliation: Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, N15W7, Kitaku, Sapporo, 060-8638, Japan. gando@med.hokudai.ac.jp.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Gando
authors.affiliation: Department of Acute Critical Care and Disaster Medicine, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyoku, Tokyo, 113-8510, Japan. otomo.accm@tmd.ac.jp.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Otomo
mesh_terms: D000818:Animals; D000991:Antithrombins / Q000378:metabolism; D004272:DNA, Mitochondrial / Q000378:metabolism; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology*; D005342:Fibrinolysis / Q000502:physiology; D024243:HMGB1 Protein / Q000378:metabolism; D006487:Hemostasis / Q000502:physiology*; D006657:Histones / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D008074:Lipoproteins / Q000378:metabolism; D009707:Nucleosomes / Q000378:metabolism; D011486:Protein C / Q000378:metabolism; D017293:Protein S / Q000378:metabolism; D012774:Shock, Traumatic / Q000378:metabolism / Q000503:physiopathology*; D013917:Thrombin / Q000378:metabolism; D018180:Thrombomodulin / Q000502:physiology; D013927:Thrombosis / Q000378:metabolism / Q000503:physiopathology*; D014945:Wound Healing / Q000502:physiology; D014947:Wounds and Injuries / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D000991:Antithrombins; D004272:DNA, Mitochondrial; D024243:HMGB1 Protein; D006657:Histones; D008074:Lipoproteins; D009707:Nucleosomes; D011486:Protein C; D017293:Protein S; D018180:Thrombomodulin; C051928:lipoprotein-associated coagulation inhibitor; D013917:Thrombin